Asset 2 Conferences
Cancer Biology

Recent insights into Immuno-Oncology (2nd edition)

30-31 May 2024, Antwerp, Belgium
Final deadline: 16 May
Immuno Oncology - campaign visual

Recent insights into Immuno-Oncology (2nd edition)

Recent insights into Immuno-Oncology (2nd edition)
Keep me postedAdd to calendar

Cancer immunotherapy has revolutionized the clinical practice in multiple advanced cancers and is a fast-developing field in oncology. Over the past decade, we witnessed an extraordinary development and progress in the field of onco-immunology. The ever-expanding knowledge of the processes beyond the success of immunotherapy leveraged novel biomarkers, next-generation cell therapies, cancer vaccines, and multi-specific antibodies, among other clinically relevant advances.

At the second edition, leading experts in cancer immunotherapy will present the latest advances in their cutting-edge research, discuss the future challenges in the field of onco-immunology, including resistance mechanisms and how to harness cellular and molecular or metabolic components of complex immune networks to optimize the combination of immunotherapy with other anticancer regimens and develop new strategies.

Compared with the first edition, the current second onco-immunology conference will focus on cellular therapies (CAR, ACT, etc.) and clinical trials), with the main aim to bring researchers closer to the most recent applications in immunotherapy.

We anticipate that the conference will provide a landmark forum to stimulate discussion and interaction among participants, researchers, healthcare professionals, and experts in this burgeoning and rapidly evolving field.

The program brings together world-recognized experts who will present their recent work in sessions focused on:

  • Car T Cells
  • Precision immuno-oncology
  • Immune-escape
  • Glycobiology in cancer
  • Cross-talk myeloid cells
  • Tumor-host interactions
  • Translational research

Next to an inspiring scientific program, conference participants will have ample networking opportunities during the breaks, poster sessions, and the conference dinner in a perfectly safe and stimulating environment.

Travel grants
We offer four travel grants to international junior scientists, which will reimburse travel costs up to 400 Euros. The deadline to participate is 7 March 2024.

Host City: Antwerp
Want to know more about the host city of this conference? Find out where the best restaurants, bars, or last-minute print shops are. Check the city page here.

Share

Confirmed speakers

Program

Day 1 - Thursday, 30 May, 2024

The program below is scheduled in CET.

08:20
08:50
Registration & welcome coffee
08:50
09:00
Welcome & opening
09:00
11:05
Session 1: Car T Cells
09:00
09:30
Metabolic interventions to improve CAR T cell therapy
09:30
10:00
Engineering macrophages for cancer immunotherapy: CAR-M and beyond
10:00
10:30
Next generation of CAR T cells: Combining targets, costimulation and logic gating.
10:30
10:35
Armoring CAR-T therapy with PD-1 blockade: a powerful strategy for enhancing anti-tumor effects in pancreatic cancer

Presenter TBA

Sponsored talk
10:35
11:05
Coffee break
11:05
12:35
Session 2: Precision Immuno-Oncology
11:05
11:35
Single T cell dynamics during aPD1 +/- aCTLA4 in triple negative breast cancer
11:35
12:05
The power of ONE: Immunology in the age of single cell genomics
12:05
12:20

Presenter TBA

Selected from abstracts
12:20
12:25
High-plex whole slide spatial biology assays for translational immuno-oncology research

Hester Koppejan

Field Application Scientist, Standard BioTools, US
Sponsored talk
12:25
13:30
Lunch
13:30
14:30
Poster session 1
14:30
17:00
Session 3: Immune Escape
14:30
15:00
Mechanisms of T cell exhaustion and implications for immune oncology.
15:00
15:30
Dissecting the lymphatic paradox: immune surveillance, immune resolution, and metastasis.
15:30
16:00
Uncovering roles for systemic immunity in metastasis and responses to immunotherapy
16:00
16:15

Presenter TBA

Selected from abstracts
16:15
16:30

Presenter TBA

Selected from abstracts
16:30
17:00
Coffee break
17:00
18:00
Session 4: Glycobiology in cancer
17:00
17:30
Sialic acid-Siglec axis, immune cell communication in the tumor microenvironment; impact on the treatment of cancer
17:30
18:00
The emerging role of glycocheckpoints: the sweet side of cancer immunotherapy

Gabriel Rabinovich

Institute of Biology and Experimental Medicine, CONICET and University of Buenos Aires, AR
18:00
19:00
Reception
19:00
22:00
Social activity & Conference dinner

Additional fee

Day 2 - Friday, 31 May, 2024

The program below is scheduled in CET.

08:30
09:00
Coffee
09:00
10:50
Session 5: Cross talk myeloid cells
09:00
09:30
Mining immunomodulatory myeloid programs in cancer
10:00
10:15

Presenter TBA

Selected from abstracts
10:15
10:20
Sponsor talk: Analis & Beckman Coulter

Presenter TBA

Sponsored talk
10:20
10:50
Coffee break
10:50
12:35
Session 6: Tumor-Host Interactions
10:50
11:20
Immune targeting of brain cancer
11:20
11:50
Impact of emergency granulopoiesis on cancer progression
11:50
12:20
Well Met: Methionine and the early establishment of T cell fate trajectories
12:20
12:35

Presenter TBA

Selected from abstracts
12:30
13:30
Lunch
13:30
14:30
Poster session 2
14:30
16:00
Session 7: Immunotherapy
14:30
15:00
Tumor PGE2 limits TIL expansion and curtails TIL therapy by collapsing IL-2 signalling and mitochondrial function in tumor-reactive cells
15:00
15:30
Targeting adrenergic receptors to increase the efficacy of cancer immunotherapy
15:30
15:45

Presenter TBA

Selected from abstracts
15:45
16:15
Coffee break
16:15
17:30
Session 8: Translational research
16:15
16:45
Functional decoding of anti-tumor T cell reactivity using genetic screens
16:45
17:00
Boosting immune cell education in solid tumors
17:00
17:30
Mining broad T cell repertoires to identify T-cell receptors to new targets.
17:30
18:00
Unleashing the full potential of CD4+ T-cell effector functions against immune-evasive tumors
18:00
18:15
Closing

Organizing committee

Abstracts

Poster information
The format for your poster should be: A0 (841 x 1189 mm / 33.1 x 46.8 in), portrait orientation.
All accepted poster submissions will have a chance to win the Nature Reviews Cancer Poster Prize!

If you're not registered before 2 May 2024, your abstract will be excluded from the abstract list and you will not have the chance to present your work at the conference.

The full list of abstracts will be available on 15-05-2024 until 30-08-2024
This list will only be available for registered attendees of the event.

Attendees

The full list of attendees will be available on 15-05-2024 until 30-08-2024
This list will only be available for registered attendees of the event.

Buy tickets for this event

Virtual & live tickets cannot be combined in the same order. 

Virtual tickets give access to the livestreamed talks and the recorded talks.
The ticket does not include any possibilities to interact with participants or to attend poster sessions.

Other available tickets

PhD student ticket
PhD student
€360.00 excl. VAT
 
Academic ticket
Academic
€460.00 excl. VAT
 
Industry ticket
Industry
€720.00 excl. VAT
 
Virtual - PhD student ticket
PhD student
€150.00 excl. VAT
 
Virtual - Academic ticket
Academic
€180.00 excl. VAT
 
Virtual - Industry ticket
Industry
€300.00 excl. VAT
 

You can also order

Conference dinner - 30 May 2024
€70.00 excl. VAT